The aim of this study was to evaluate the safety , pharmacokinetics , and clinical response of brodalumab ( AMG @ ) , a human , anti-IL-@ receptor A ( IL-@RA ) monoclonal antibody in subjects with moderate-to-severe rheumatoid arthritis ( RA ) .